Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The CBF has finished the importation, labelling and certification of the cAd3 ebola vaccine. The trial was fast tracked by the MHRA and ethics committee in record time, allowing the Phase I trial lead by Prof Adrian Hill from the Jenner Institute to begin today.

vaccination.jpegWe delivered the adenovirus vaccine to the clinical trial site this morning and the first of 60 volunteers is vaccinated today.

Please see the Nuffield Department of Medicine article for a news roundup.